Hospital Quality Improvement Initiative


TMF Health Quality Institute helps hospitals participating in the Hospital Quality Improvement Initiative (HQIC) reduce all-cause patient harm and readmissions in rural, medically underserved and vulnerable populations. The Centers for Medicare & Medicaid Services has contracted with TMF to work with qualifying hospitals. Together, we will identify solutions to improve health care outcomes and improve patient care in your facility.

As a member of the HQIC network, you have access to the latest news, resources, learning opportunities and forum discussions. Your hospital and health care providers work hard every day to provide safe reliable quality care. TMF looks forward to partnering with you to improve the effectiveness, efficiency, economy and quality of services delivered to your patients.

These items also available in the Resource Library 
FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations
The Food and Drug Administration (FDA) has amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the vaccine’s primary series in certain populations.
CMS News: QPP Website Will No Longer Support IE 11 Browser
As of Oct. 13, 2021, users won’t be able to access the Quality Payment Program (QPP) website,, using the IE 11 browser. The QPP website will continue to support modern browsers such as Google Chrome and Microsoft Edge. IE 11 users will need to download one of these browsers in order to access
Hurricane Ida Added to Automatic Extreme and Uncontrollable Circumstances Policy for MIPS
The automatic extreme and uncontrollable circumstances (EUC) policy will apply to MIPS-eligible clinicians in FEMA-designated disaster areas (Louisiana, Mississippi and Missouri). They will be automatically identified and receive a neutral payment adjustment for the 2023 MIPS payment year. For the 2021 performance period, all four performance categories will be weighted at 0%. The EUC won’t apply to clinicians participating in MIPS as a group, virtual group, or Alternative Payment Model (APM).
Anti-SARS-CoV-2 Antibody Products
Clinicians seeking advice on the use of monoclonal antibody products authorized for emergency use in the United States for the treatment and prevention of SARS-CoV-2 should consult the National Institutes of Health COVID-19 Treatment Guidelines.
CMS Announces Support, Waivers for Residents of Louisiana and Mississippi
The Centers for Medicare & Medicaid Services (CMS) has announced flexibilities to ensure health care access continues for residents in Louisiana and Mississippi impacted by Hurricane Ida. CMS is also notifying Louisiana and Mississippi of the resources and waivers being made available to ensure hospitals and other facilities can continue to operate and provide access to care to those impacted by Hurricane Ida.
1 2 3 4 5Next